
As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.
Humana on Wednesday posted a second-quarter adjusted EPS of $6.27, down from $6.96 a year ago, beating the consensus of $5.90.